These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 32944459

  • 1. Recall Rates of Total Knee Arthroplasty Devices Are Dependent on the FDA Approval Process.
    Pellerin C, Adamson M, Janney C.
    Cureus; 2020 Aug 14; 12(8):e9744. PubMed ID: 32944459
    [Abstract] [Full Text] [Related]

  • 2. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
    Peters W, Pellerin C, Janney C.
    Biomed Instrum Technol; 2020 Nov 01; 54(6):418-426. PubMed ID: 33339030
    [Abstract] [Full Text] [Related]

  • 3. Analysis of FDA-Approved Orthopaedic Devices and Their Recalls.
    Day CS, Park DJ, Rozenshteyn FS, Owusu-Sarpong N, Gonzalez A.
    J Bone Joint Surg Am; 2016 Mar 16; 98(6):517-24. PubMed ID: 26984921
    [Abstract] [Full Text] [Related]

  • 4. An Analysis of Foot and Ankle Device Recalls by the Food and Drug Administration.
    Pellerin C, Panchbhavi V, Janney CF.
    Cureus; 2018 Aug 09; 10(8):e3123. PubMed ID: 30338198
    [Abstract] [Full Text] [Related]

  • 5. The Complex Process of Using the Interconnected Knee Arthroplasty Device Clearance Pathway.
    Zhu A, Ying X, Pean CA, Sheth NP, Cross MB, Gonzalez Della Valle A, Premkumar A.
    HSS J; 2022 Nov 09; 18(4):462-468. PubMed ID: 36258781
    [Abstract] [Full Text] [Related]

  • 6. Risk of Recall Among Medical Devices Undergoing US Food and Drug Administration 510(k) Clearance and Premarket Approval, 2008-2017.
    Dubin JR, Simon SD, Norrell K, Perera J, Gowen J, Cil A.
    JAMA Netw Open; 2021 May 03; 4(5):e217274. PubMed ID: 33956132
    [Abstract] [Full Text] [Related]

  • 7. How do Orthopaedic Devices Change After Their Initial FDA Premarket Approval?
    Samuel AM, Rathi VK, Grauer JN, Ross JS.
    Clin Orthop Relat Res; 2016 Apr 03; 474(4):1053-68. PubMed ID: 26584802
    [Abstract] [Full Text] [Related]

  • 8. Shoulder arthroplasty device clearance: an ancestral network analysis.
    Zhu A, Ying X, Carey EG, Pean CA, Premkumar A, Fu MC, Taylor SA.
    J Shoulder Elbow Surg; 2023 Mar 03; 32(3):671-676. PubMed ID: 36279987
    [Abstract] [Full Text] [Related]

  • 9. Orbital Implants Receiving Food and Drug Administration Premarket Notification.
    Corcoran Ruiz KM, Vaishnav YJ, Desautels J, Schaefer JL, Migliori ME, Yilmaz T.
    Ophthalmic Plast Reconstr Surg; 2023 Mar 03; 38(5):503-506. PubMed ID: 35699217
    [Abstract] [Full Text] [Related]

  • 10. Risk of Recall for Total Joint Arthroplasty Devices Over 10 Years.
    DeRuyter MT, Mansy LN, Krumme JW, Cheng AL, Dubin JR, Cil A.
    J Arthroplasty; 2023 Aug 03; 38(8):1444-1448. PubMed ID: 36773660
    [Abstract] [Full Text] [Related]

  • 11. Recalls of Moderate- and High-Risk Otolaryngologic Devices Approved by the US Food and Drug Administration, 2003-2019.
    Talati IA, Parsa KM, Gao WZ.
    Otolaryngol Head Neck Surg; 2022 Nov 03; 167(5):832-838. PubMed ID: 35290135
    [Abstract] [Full Text] [Related]

  • 12. Assessment of Obstetric and Gynecologic Food and Drug Administration Device Approvals and Recalls.
    Galhotra S, Maurice J.
    J Minim Invasive Gynecol; 2018 Nov 03; 25(7):1281-1288. PubMed ID: 29653261
    [Abstract] [Full Text] [Related]

  • 13. The Interconnected Ancestral Network of Hip Arthroplasty Device Approval.
    Premkumar A, Zhu A, Ying X, Pean CA, Sheth NP, Cross MB, Gonzalez Della Valle A.
    J Am Acad Orthop Surg; 2021 Dec 15; 29(24):e1362-e1369. PubMed ID: 34161960
    [Abstract] [Full Text] [Related]

  • 14. Medical device recalls and the FDA approval process.
    Zuckerman DM, Brown P, Nissen SE.
    Arch Intern Med; 2011 Jun 13; 171(11):1006-11. PubMed ID: 21321283
    [Abstract] [Full Text] [Related]

  • 15. Assessment of cardiovascular and noncardiovascular medical device recalls.
    Somberg JC, McEwen P, Molnar J.
    Am J Cardiol; 2014 Jun 01; 113(11):1899-903. PubMed ID: 24837271
    [Abstract] [Full Text] [Related]

  • 16. Incremental Revisions across the Life Span of Ophthalmic Devices after Initial Food and Drug Administration Premarket Approval, 1979-2015.
    Gopal AD, Rathi VK, Teng CC, Del Priore L, Ross JS.
    Ophthalmology; 2017 Aug 01; 124(8):1237-1246. PubMed ID: 28501378
    [Abstract] [Full Text] [Related]

  • 17. Orthopaedic Device Approval Through the Premarket Approval Process: A Financial Feasibility Analysis for a Single Center.
    Yang BW, Iorio ML, Day CS.
    J Bone Joint Surg Am; 2017 Mar 15; 99(6):e26. PubMed ID: 28291189
    [Abstract] [Full Text] [Related]

  • 18. Association Between Regulatory Submission Characteristics and Recalls of Medical Devices Receiving 510(k) Clearance.
    Everhart AO, Sen S, Stern AD, Zhu Y, Karaca-Mandic P.
    JAMA; 2023 Jan 10; 329(2):144-156. PubMed ID: 36625811
    [Abstract] [Full Text] [Related]

  • 19. Characteristics of Clinical Studies Conducted Over the Total Product Life Cycle of High-Risk Therapeutic Medical Devices Receiving FDA Premarket Approval in 2010 and 2011.
    Rathi VK, Krumholz HM, Masoudi FA, Ross JS.
    JAMA; 2015 Aug 11; 314(6):604-12. PubMed ID: 26262798
    [Abstract] [Full Text] [Related]

  • 20. Risk of Recall Associated With Modifications to High-risk Medical Devices Approved Through US Food and Drug Administration Supplements.
    Dubin JR, Enriquez JR, Cheng AL, Campbell H, Cil A.
    JAMA Netw Open; 2023 Apr 03; 6(4):e237699. PubMed ID: 37043202
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.